Impact of inherited bleeding disorders on maternal bleeding and other pregnancy outcomes: A population‐based cohort study
Haemophilia · 2024
DOI: 10.1111/hae.14922 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Haemophilia, 2024. Verfasst von Arafat Ul Alam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Alberta, Edmonton, Canada. Hauptthemen laut MEDLINE: Hemophilia A, Postpartum Hemorrhage, von Willebrand Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Marshall Eliuk Fund for Clinical Innovation in Haematology, University of Alberta.
Abstract (Originalsprache)
Introduction
Increasing rate of postpartum haemorrhage (PPH) has been observed between 2003 and 2010 in Canada. Inherited bleeding disorders contribute to the risk of PPH.
Aim
To identify the trend in PPH in the last decade, assess the impact of bleeding disorders on pregnancy outcomes and evaluate their coagulation workup during pregnancy.
Methods
We conducted a population‐based retrospective cohort study using the Alberta Pregnancy Birth Cohort from 2010 to 2018. We included women with von Willebrand disease (VWD) and haemophilia, identified by previously validated algorithm and matched with controls. Logistic regression was used to compute odds of PPH and other pregnancy outcomes.
Results
We identified 311,330 women with a total of 454,400 pregnancies with live births. The rate of PPH did not change significantly from 10.13 per 100 deliveries (95% CI 10.10–10.16) in 2010–10.72 (95% CI 10.69–10.75) in 2018 ( p for trend = .35). Women with bleeding disorders were significantly more likely to experience PPH (odds ratio [OR] 2.3; 95% CI 1.5–3.6), antepartum haemorrhage (OR 2.9; 95% CI 1.5–5.9) and red cell transfusion (OR 2.8; 95% CI 1.1–7.0). We observed a nonsignificant rise in the rate of PPH in women with VWD and haemophilia. Only 49.5% pregnancies with bleeding disorders had third trimester coagulation factor levels checked. Higher odds of PPH and antepartum haemorrhage were observed even with factor levels ≥0.50 IU/mL in third trimester.
Conclusion
Despite comprehensive care in women with bleeding disorders, they are still at higher risk of adverse pregnancy outcomes compared to population controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Alberta, Edmonton, Canada.
- Division of Hematology, Department of Medicine, University of Alberta, Edmonton, Canada.
- Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Canada.
ORCID-Profile: Arafat Ul Alam, Haowei Linda Sun
Förderung
- Marshall Eliuk Fund for Clinical Innovation in Haematology, University of Alberta
Zitieren
APA
Alam, A. U., Wu, C., Kaul, P., Jain, V., & Sun, H. L. (2024). Impact of inherited bleeding disorders on maternal bleeding and other pregnancy outcomes: A population‐based cohort study. Haemophilia. https://doi.org/10.1111/hae.14922
Vancouver
Alam AU, Wu C, Kaul P, Jain V, Sun HL. Impact of inherited bleeding disorders on maternal bleeding and other pregnancy outcomes: A population‐based cohort study. Haemophilia. 2024. doi:10.1111/hae.14922
BibTeX
@article{Alam2024,
author = {Alam, Arafat Ul and Wu, Cynthia and Kaul, Padma and Jain, Venu and Sun, Haowei Linda},
title = {Impact of inherited bleeding disorders on maternal bleeding and other pregnancy outcomes: A population‐based cohort study},
journal = {Haemophilia},
year = {2024},
doi = {10.1111/hae.14922}
}
EUVIMED